BOTOX(R) (OnabotulinumtoxinA) Receives FDA Approval for Treatment of … – StreetInsider.com
2010 March 10
Irvine, California – (BUSINESS WIRE) – Allergan Inc. (NYSE: AGN) has announced that the U.S. Food and Drug Administration (FDA) has approved for the treatment of Clostridium botulinum to increase muscle stiffness (R) (onabotulinumtoxinA) in the elbow, wrist and …
Read More
